Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Gilead Sciences Expands Liver Portfolio With Acquisition of CymaBay Therapeutics
Tuesday, February 13, 2024Gilead Sciences Inc and CymaBay Therapeutics Inc have announced a definitive agreement today with Gilead set to acquire CymaBay for per share in cash totaling an equity value of billion
Nuvig Launches Clinical Development for NVG-2089, its Latest Immune Modulator
Monday, February 12, 2024Nuvig Therapeutics Inc a privately held biotech company has announced the commencement of human trials for NVG its proprietary product The therapy targets inflammatory myopathies
Vicore Pharma and Nippon Shinyaku Forge Exclusive License Partnership for C21 Development and Marketing in Japan
Saturday, February 10, 2024Vicore Pharma Holding AB has made a significant stride in its efforts to advance a novel class of drug candidates angiotensin II type receptor agonists The company announced today the signing of an exclusive licensing agreement
Amneal Submits Revised Application for IPX203 New Drug Approval
Friday, February 09, 2024Amneal Pharmaceuticals Inc has announced its submission of a Complete Response resubmission to the US Food and Drug Administration for IPX an innovative oral formulation of carbidopalevodopa extendedrelease capsules aimed at treating Parkinsons disea...
Genprex Partners with Researchers to Expand Nonclinical Programs into New Therapeutic Indications
Thursday, February 08, 2024Genprex Inc a clinicalstage innovator in gene therapy focusing on groundbreaking treatments for cancer and diabetes patients has announced the expansion of its nonclinical programs
Pacira Biosciences Secures Agreement for Brand Pharmaceuticals with Premier, Inc
Thursday, February 08, 2024Pacira BioSciences Inc known for its focus on nonopioid pain management and regenerative health solutions has secured a national group purchasing agreement for Brand Pharmaceuticals
BridgeBio Pharma and Kyowa Kirin Forge Partnership with $100 Million Upfront Payment for Exclusive License of Infigratinib in Skeletal Dysplasias in Japan
Wednesday, February 07, 2024BridgeBio Pharma Inc and Kyowa Kirin Co Ltd have announced a significant partnership Under this agreement BridgeBios affiliate QED Therapeutics has granted Kyowa Kirin an exclusive license to develop and commercialize infigratinib
NouvNeu001 Hits Milestone with Successful Dosing of First Patient in iRegene Therapeutics' Multicenter Clinical Trial for Novel Parkinson's Disease Therapy
Tuesday, February 06, 2024IRegene Therapeutics Co Ltd recently made an important announcement regarding the progress of NouvNeu their innovative product They reported the completion of dosing for the first patient at Beijing Hospital
Fermion's TYK2 JH2 Inhibitor FZ007-119 Receives IND Approval from China's NMPA
Monday, February 05, 2024Fermion a clinicalstage pharmaceutical company focused on autoimmune diseases and pain management is delighted to announce the approval of its Investigational New Drug application for FZ by the China National Medical Products Administration
Junshi Biosciences Has Revealed That the Singapore Health Sciences Authority Has Accepted the New Drug Application for Toripalimab
Saturday, February 03, 2024Shanghai Junshi Biosciences Co Ltd has disclosed that the Singapore Health Sciences Authority accepted the New Drug Application for toripalimab This application includes the use of toripalimab in combination with cisplatin
